/
/
Myeloma Crowd Research Initiative: COVID-19 and Multiple Myeloma Study
Myeloma Crowd Research Initiative: COVID-19 and Multiple Myeloma Study image
Myeloma Crowd Research Initiative: COVID-19 and Multiple Myeloma Study
Posted Nov 09, 2020

In April of 2020 when the COVID-19 pandemic hit in full force, we launched a study to determine the impacts COVID-19 has had on myeloma patients. Within four weeks, over 1,100 patients had participated. The study was led by myeloma experts Dr. Rafael Fonseca, Dr. Faith Davies, Dr. Caitlin Costello, Dr. Ola Landgren, Dr. Mike Thompson and Dr. Ivan Borrello to better understand which myeloma patients are most at risk and how they are being affected by the virus. 

As the pandemic has extended over a longer period of time than anyone anticipated, during the rest of 2020 and into 2021 we will follow each of the patients in the study and ask follow up questions to determine the long-term impact of the virus on patient care and outcomes. We will track patients who have tested positive for COVID-19 and understand their outcomes.

Using HealthTree, myeloma patients will be able to help inform one another in a constantly changing coronavirus landscape.

The anonymous answers will be aggregated and analyzed by myeloma researchers to identify recommendations that will help all myeloma patients know how best be protected and effectively treated for both COVID-19 and their myeloma.

Please donate to this important study and continue in the study if you were a prior participant. If you would like to join the study, all MGUS, smoldering myeloma and multiple myeloma patients are welcome. To join the current study, click here. 

To pre-register for additional MCRI studies, complete the information below. 

 

 

Donate to the MCRI and COVID study 

 

Matching Gifts

Did you know that many companies offer a matching gift program to encourage philanthropy among the employees? By simply completing a matching gift form online you may be able to double, or even triple, the impact of your donation! Contributions of any amount help contribute and fund groundbreaking research for high-risk diseases. 

Use the search field below to see if your employee participants in the matching gift program. For questions regarding your matching gift, please email matching@crowdcare.org.

Matching Gift and Volunteer Grant information provided by
Powered by Double the Donation

 

The CrowdCare Foundation (now named the HealthTree Foundation) and Myeloma Crowd is a registered 501(c)3 non-profit, tax ID 45-5354811.

 

The author Jennifer Ahlstrom

about the author
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of Myeloma Crowd by HealthTree and the HealthTree Foundation.

More Myeloma Crowd Research Initiative Articles

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811